PhaseBio says biopolymer delivery tech could cut insulin injections
Diabetes sufferers could be injecting insulin just once a week if a new drug delivery technique is picked up by a big pharma company.
Archives for January 31, 2013
EMA Offers Inside Look at Clinical Trial Inspections
Clinical trial inspectors are being called on by the European Medicines Agency (EMA) to focus their efforts more on findings that are likely to impact the benefit-risk evaluation of a drug.
Parexel Exceeds Expectations in Q2, Analysts Skeptical About Future
Parexel may have raised its forecast for fiscal 2013 after reporting a 26% hike in second quarter revenues this week, but analysts still have concerns about its spending.
JLL bids $123m for Bioclinica and plans imaging bolt-on
Bioclinica has agreed to a takeover by JLL Partners in a deal that would see the eClinical provider merge with medical imaging firm CoreLab Partners.
Flublok maker open to sharing egg and virus-free manufactuing tech
Protein Sciences says it will license the novel manufacturing technology behind recently approved influenza vaccine, Flublok, to other producers.
Cytovance ups biologics capacity as small pharma demand rises
Cytovance Biologics says an increase in demand from small pharma was the driving force in expanding its biologics capacity.
Lonza hints at manufacturing cuts
Lonza says it will “move from a product-oriented to a market-oriented organisation” suggesting a restructuring of its manufacturing division is on the cards.